Cat Inflammatory Bowel Disease: Welfare and Diet

Feline inflammatory bowel disease (IBD) causes chronic gastrointestinal dysfunction with significant welfare impacts, requiring careful dietary and medical management.

Key Facts

Feline IBD involves chronic immune-mediated inflammation of the small intestine, large intestine, or stomach
Clinical signs include chronic vomiting, diarrhoea, weight loss, and poor body condition
Diagnosis requires endoscopy and biopsy, as clinical signs overlap with other conditions including lymphoma
Hydrolysed protein or novel protein diets can produce significant improvement in some cats
Corticosteroids (prednisolone) and chlorambucil are used for moderate to severe IBD

Welfare Considerations

IBD causes chronic gastrointestinal discomfort and nutritional depletion that progressively compromises welfare. Cats with uncontrolled IBD experience repeated vomiting, diarrhoea, and the malaise of chronic inflammation and weight loss. The distinction between IBD and small cell lymphoma (SCL) is critical — both are treated with similar protocols but SCL carries a different long-term prognosis. Response to dietary management alone in some cats avoids the need for immunosuppressive medication with its associated side effects. Monitoring weight, body condition, and vomiting frequency provides objective welfare tracking for cats with IBD on management programmes.

What You Can Do

Seek endoscopy and biopsy for definitive diagnosis of IBD rather than treating empirically without tissue diagnosis
Trial a strict hydrolysed or novel protein diet for 8 weeks before initiating medical management if IBD is confirmed
Monitor weight at minimum monthly to detect nutritional deterioration early in IBD-managed cats
Discuss the distinction between IBD and intestinal lymphoma with your veterinarian to ensure appropriate treatment